Overview

An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant

Status:
Completed
Trial end date:
2011-11-30
Target enrollment:
Participant gender:
Summary
This observational study will investigate efficacy and safety of methoxy polyethyleneglycol-epoetin beta in participants with a kidney transplant. Data of each participant will be collected over 15 months of Mircera therapy.
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Epoetin Alfa